Problem first. Weight loss, tendon recovery, gut symptoms, skin, libido, or cognition.
Access path second. Prescription, provider, pharmacy, vendor, topical, or avoid.
Click path third. Tool, source check, matrix, calculator, or safety page.
What people are usually doing today
Protocol One sees six patterns. The same peptide name can sit in very different risk buckets depending on how someone is getting it.
| Path | Typical examples | Protocol One next step |
|---|---|---|
| FDA-approved prescription | Wegovy, Zepbound, Ozempic, Mounjaro, Vyleesi, Egrifta | Read the dosing page, then compare providers only if access or cost is the blocker. |
| Telehealth provider | GLP-1 programs, weight-loss consults, branded prescription routing | Run readiness first, then run the provider trust report before paying. |
| Compounded pharmacy | Cash-pay compounded semaglutide or tirzepatide, prescribed BPC-157 claims | Check prescriber, named pharmacy, pricing, and product-quality evidence. |
| Research vendor | BPC-157, TB-500, MOTS-c, CJC-1295, Ipamorelin, GHK-Cu injectable | Source verification comes before calculator, coupon, or protocol. |
| Cosmetic topical | GHK-Cu serums, skin and hair products | Lower route risk than injectable, but still check ingredient identity and vendor claims. |
| Gray-market or emergency | DMs, gym vials, Telegram, wrong bottle, accidental overdose, retatrutide sales | Stop. Use the safety page or a clinician. Do not let a calculator make this look clean. |
Choose the closest situation
This is the operating layer for the site. Each card routes to the tool or page that best matches the risk and commercial path.
I know the problem, not the peptide.
Use this for tendon recovery, gut symptoms, weight loss, libido, skin, cognition, sleep, or immune questions. The molecule comes second.
Run the master quiz -> GLP-1 decisionI am wondering if a GLP-1 conversation makes sense.
Check food noise, BMI, metabolic flags, midlife concerns, coverage reality, and clinician-first safety flags before provider shopping.
Run readiness report -> Provider offerI found a GLP-1 provider and need to know if it is legit.
Score price, named pharmacy, prescriber model, compounded-drug language, safety flags, and public audit status before payment.
Run provider trust report -> Ready to compareI want the GLP-1 provider matrix.
Use this after you understand the route. It is the commercial comparison page with affiliate disclosures and provider caveats.
Compare GLP-1 providers -> Source checkI am looking at BPC-157, a vial, or a source claim.
Check prescription label, named pharmacy, COA, lot, sterility, endotoxin, follow-up, and research-only red flags before dose math.
Check the source -> Vendor educationI need to understand COAs, labs, and vendor claims.
Use this when you are comparing research-vendor pages and need to separate identity testing from human-use safety.
Learn source vetting -> Dose mathMy source and dose are already clear. I need syringe math.
Use the calculator only after identity, route, vial size, concentration, and prescribed or intended dose are clear.
Open calculator -> Stop pathWrong vial, too much, bad reaction, or emergency concern.
This is not a commercial path. Use Poison Control, 911, or a clinician. Do not troubleshoot an emergency with a dosing page.
Open safety page ->Why this is the goal loop
Revenue is downstream of qualified traffic and qualified clicks. A generic article reader can subscribe. A GLP-1 shopper can move toward a provider report or matrix. A BPC-157 reader needs source confidence before math. A retatrutide buyer needs an avoid path. The loop is to map each high-impression page to the right route, then measure whether that next step earns clicks.
Current source anchors
Protocol One keeps this router conservative because the category moves. These are the source anchors we use for risk framing and safe-online-pharmacy language: